BRIEF published on 06/26/2025 at 17:48, 7 months 16 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
PRESS RELEASE published on 06/26/2025 at 17:43, 7 months 16 days ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE's Annual General Meeting approves divident distribution of EUR 0.90 per share for 2024, confirms 2025 outlook and ratifies Board actions Annual General Meeting Financial Year 2024 Dividend Distribution Dermapharm Holding SE EUR 0.90 Per Share
BRIEF published on 05/15/2025 at 07:35, 8 months 28 days ago Dermapharm Holding SE répond aux attentes du premier trimestre 2025 et renforce ses prévisions pour l'ensemble de l'année Croissance Des Revenus Baisse De L'EBITDA Orientation Pour L'année Entière Produits Pharmaceutiques De Marque Dermapharm T1 2025
BRIEF published on 05/15/2025 at 07:35, 8 months 28 days ago Dermapharm Holding SE Meets Q1 2025 Expectations, Reinforces Full-Year Forecast Revenue Growth Full-year Guidance EBITDA Decline Branded Pharmaceuticals Dermapharm Q1 2025
PRESS RELEASE published on 05/15/2025 at 07:30, 8 months 28 days ago Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance Dermapharm Holding SE reports Q1 2025 results in line with projections, confirming full-year guidance. Revenue increases by 1.2% year-on-year to EUR 302.4 million Adjusted EBITDA Revenue Growth Dermapharm Holding SE Full-year Guidance Q1 2025 Results
BRIEF published on 03/28/2025 at 07:35, 10 months 15 days ago Les résultats financiers de Dermapharm en 2024 dépassent les attentes Augmentation Des Revenus Croissance De L'EBITDA Résultats Financiers 2024 Produits Pharmaceutiques De Marque Dermapharm
BRIEF published on 03/28/2025 at 07:35, 10 months 15 days ago Dermapharm's 2024 Financial Performance Exceeds Expectations Revenue Increase EBITDA Growth Branded Pharmaceuticals Financial Results 2024 Dermapharm
PRESS RELEASE published on 03/28/2025 at 07:30, 10 months 15 days ago Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance Dermapharm Holding SE reports successful financial year 2024 with increased revenue and exceeded EBITDA guidance. Full details in Annual Report Revenue Increase Financial Year 2024 EBITDA Guidance Annual Report Dermapharm Holding SE
BRIEF published on 03/14/2025 at 07:35, 10 months 29 days ago Dermapharm Holding SE augmente son chiffre d'affaires et dépasse les prévisions d'EBITDA Proposition De Dividende Produits De Santé Croissance De L'EBITDA Produits Pharmaceutiques De Marque Chiffre D'affaires De Dermapharm
BRIEF published on 03/14/2025 at 07:35, 10 months 29 days ago Dermapharm Holding SE Increases Revenue and Exceeds EBITDA Guidance Dividend Proposal EBITDA Growth Healthcare Products Branded Pharmaceuticals Dermapharm Revenue
Published on 02/12/2026 at 17:00, 2 hours 16 minutes ago Diamcor Provides Update on Discharge of Security and Indebtedness, and Granting of Extension of Time to Hold the 2025 Annual General Meeting
Published on 02/12/2026 at 15:00, 4 hours 16 minutes ago Onco-Innovations Announces Amendment to Private Placement Pricing
Published on 02/12/2026 at 14:30, 4 hours 46 minutes ago MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/12/2026 at 14:30, 4 hours 46 minutes ago Loar Holdings Inc. Announces Date and Time for Fourth Quarter and Full Year 2025 Earnings Conference Call
Published on 02/12/2026 at 17:45, 1 hour 31 minutes ago ENOGIA: Chiffre d’affaires de l’exercice 2025 : +57% (12,6 M€)
Published on 02/12/2026 at 17:45, 1 hour 31 minutes ago ENOGIA: FY 2025 revenue: +57% (€12.6 million)
Published on 02/12/2026 at 17:31, 1 hour 44 minutes ago R. STAHL launches development program for the future and withdraws from employer association
Published on 02/12/2026 at 17:08, 2 hours 8 minutes ago Siltronic releases its guidance for financial year 2026
Published on 02/12/2026 at 17:45, 1 hour 31 minutes ago MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY
Published on 02/12/2026 at 17:45, 1 hour 31 minutes ago Mr.Bricolage : Mise en place d'un nouveau contrat de crédit
Published on 02/12/2026 at 17:45, 1 hour 31 minutes ago Chiffre d’affaires des 9 premiers mois de l’exercice 2025/2026
